Inventor · disambiguated record
Christine Klaus
Also filed as: KLAUS CHRISTINE
17 granted patents·12 pending applications·296 citations·filing 2012–2024
95Inventor score
Top patents by PatentIndex Score
29 records- 0198US9549931B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Jan 24, 2017·39 cites·21 claims
- 0298US9522152B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2015·Granted Dec 20, 2016·32 cites·8 claims
- 0398US9090562B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2014·Granted Jul 28, 2015·51 cites·20 claims
- 0498US8765732B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2012·Granted Jul 1, 2014·66 cites·19 claims
- 0596US11052093B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2019·Granted Jul 6, 2021·7 cites·20 claims
- 0696US10155002B2Aryl- or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2016·Granted Dec 18, 2018·16 cites·29 claims
- 0796US9855275B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Jan 2, 2018·18 cites·30 claims
- 0895US10420775B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2017·Granted Sep 24, 2019·12 cites·20 claims
- 0995US9446064B2Combination therapy for treating cancerEPIZYME INC·Filed 2014·Granted Sep 20, 2016·22 cites·23 claims
- 1093US10525074B2Combination therapy for treating cancerEPIZYME INC·Filed 2016·Granted Jan 7, 2020·7 cites·23 claims
- 1192US12168015B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·2 claims
- 1292US12161645B2Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 10, 2024·0 cites·10 claims
- 1391US12168016B2Aryl-OR heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Granted Dec 17, 2024·0 cites·12 claims
- 1491US11642346B2Combination therapy for treating cancerEPIZYME INC·Filed 2018·Granted May 9, 2023·5 cites·8 claims
- 1591US2025170138A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2024·Application pending·0 cites
- 1690US11672800B2Combination therapies with EHMT2 inhibitorsEPIZYME INC·Filed 2018·Granted Jun 13, 2023·5 cites·20 claims
- 1790US9376422B2Dihidropyridin-2-one benzamine compoundsKUNTZ KEVIN WAYNE·Filed 2012·Granted Jun 28, 2016·16 cites·19 claims
- 1878US2021379076A1Aryl-or heteroaryl-substituted benzene compoundsEPIZYME INC·Filed 2021·Application pending·0 cites
- 1971US2024041895A1Combination therapy for treating cancerEPIZYME INC·Filed 2023·Application pending·0 cites
- 2067US2023364086A1Combination therapies with ehmt2 inhibitorsEPIZYME INC·Filed 2023·Application pending·0 cites
- 2161US2023087806A1Methods of using ehmt2 inhibitorsEPIZYME INC·Filed 2021·Application pending·0 cites
- 2260US2020030355A1Combination therapy for treating cancerEPIZYME INC·Filed 2019·Application pending·0 cites
- 2356US11291675B26′-sialyllactose for use in the treatment of hearing lossUNIV BONN RHEINISCHE FRIEDRICH WILHELMS·Filed 2018·Granted Apr 5, 2022·0 cites·15 claims
- 2454US2020113901A1Methods of using ehmt2 inhibitorsEPIZYME INC·Filed 2018·Application pending·0 cites
- 2552US2016045531A1Combination therapy for treating cancerEPIZYME INC·Filed 2014·Application pending·0 cites
- 2651US2017232030A1Combination therapy for treating cancerEPIZYME INC·Filed 2015·Application pending·0 cites
- 2745US2016332969A1Substituted benzene compoundsEPIZYME INC·Filed 2016·Application pending·0 cites
- 2841US2018028552A1Combination therapy for treating cancerEPIZYME INC·Filed 2016·Application pending·0 cites
- 2940US2019083521A1Combination therapy for treating cancerEPIZYME INC·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Christine Klaus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →